Header

Header

Header

Peptide–Affinity Tag Conjugates

Custom biotinylated peptides and affinity-tagged peptide conjugates for capture, immobilization, and assay development (project-dependent).

Custom non-drug peptide–affinity tag conjugation for capture, immobilization, and assay development.

Overview

Peptide–affinity tag conjugates are non-drug peptide conjugates in which a peptide is covalently linked to a small-molecule tag that enables selective capture, enrichment, immobilization, or detection in research workflows. These constructs are widely used in pull-down assays, interaction studies, surface immobilization, and assay development where reproducible binding and low background are important. [1], [2]

Bio-Synthesis builds chemically defined peptide–affinity tag conjugates using site-defined attachment (N-/C-terminus, single-Cys, or handle-enabled options; project-dependent), with purification and fit-for-purpose analytical confirmation to support research-stage and preclinical programs.

The most common platform is biotinylation (biotin–streptavidin/avidin systems), but alternative tags—such as desthiobiotin (reversible capture), digoxigenin (DIG) (antibody-based detection), or hapten tags like DNP—may be selected based on assay format and downstream handling needs. [1], [3]

Successful affinity tagging typically depends on site-defined attachment (e.g., N-terminus, C-terminus, a single engineered Cys, or a dedicated handle; project-dependent) and appropriate spacer design (e.g., PEG spacers) to reduce steric interference and preserve peptide binding/structure. [4]

peptide affinity tag conjugation biotinylated peptides desthiobiotin (reversible capture) DIG / hapten tags site-defined attachment ISO 9001:2015 / ISO 13485:2016
Schematic of a peptide–affinity tag conjugate showing peptide, linker or PEG spacer, and an affinity tag such as biotin.
Figure: Representative peptide + linker/PEG spacer + affinity tag architecture (biotin shown as an example).

Related: Non-drug peptide–ligand conjugates · Peptide–fluorophore conjugates

Affinity tag categories & representative items

Expand each category to see representative tags, typical applications, and practical notes. Tag and spacer selection are project-dependent.

Biotinylated peptides astreptavidin/avidin capture • immobilization
biotin biotin-PEG site-defined

Biotin is widely used due to strong binding to streptavidin/avidin, supporting capture, enrichment, and surface immobilization workflows. Spacer choice (e.g., PEG) can reduce steric effects in binding or capture formats.

Representative items Typical applications Notes
Biotin (standard) Pull-down assays, immobilization, SPR/BLI capture, ELISA-style workflows Very strong binding; consider spacer to reduce steric hindrance
Biotin-PEG (short/medium) Surface capture with improved accessibility PEG length is selected case-by-case based on assay geometry

View details: Biotinylated peptides →

Desthiobiotin peptides (reversible capture) elutable • enrichment workflows
desthiobiotin reversible capture

Desthiobiotin can be used when reversible capture/elution is preferred. It is commonly considered for workflows that benefit from gentler recovery.

Representative items Typical applications Notes
Desthiobiotin Elutable pull-downs, enrichment, capture-and-release workflows Binding is typically weaker than biotin; workflow-specific optimization may be needed
Desthiobiotin-PEG Improved accessibility in capture formats Spacer length helps reduce steric limitations on beads/surfaces

View details: Desthiobiotin peptides →

Digoxigenin (DIG)–peptide conjugates antibody detection • immunoassays
DIG anti-DIG detection

DIG is a hapten recognized by anti-DIG antibodies and is used for antibody-based detection and assay development workflows.

Representative items Typical applications Notes
Digoxigenin (DIG) Immunoassays, detection, affinity-based readouts (antibody platform dependent) Choose attachment site/spacer to preserve peptide function and antibody accessibility

View details: DIG–peptide conjugates →

Hapten tags (e.g., DNP) & platform-defined tags custom detection • platform dependent
DNP hapten custom

Hapten tags (e.g., DNP) may be used for platform-defined antibody detection or custom assay formats. Tag selection is driven by the capture/detection system and experimental constraints.

Representative items Typical applications Notes
Dinitrophenyl (DNP) Antibody-based detection in assay development (platform dependent) Typically used as a hapten; optimize spacer/site for accessibility
Project-defined affinity ligands Custom capture/detection workflows Feasibility depends on ligand chemistry and stability

View details: Hapten-tag conjugates →

Design considerations

Attachment site selection

N-terminus, C-terminus, single-Cys, or handle-enabled chemistries can be used to control stoichiometry (project-dependent).

  • Choose sites to preserve peptide binding/structure.
  • Avoid blocking key motifs if activity depends on free termini.

Spacer & accessibility

PEG or other spacers are commonly considered to reduce steric interference in capture formats.

  • Spacer length is assay-dependent.
  • Optimize for bead/surface immobilization geometry.

Assay platform fit

Select tags compatible with your detection/capture system (streptavidin, antibody, or custom platform).

  • Confirm buffer/solvent compatibility.
  • Plan controls for nonspecific binding if required.
Tip: If you are unsure which tag to choose, share your assay format (beads vs surface, antibody vs streptavidin, elution needs), and we can recommend a tag/spacer approach (project-dependent).

Workflow: from design to delivery

1) Scope & plan

Confirm peptide sequence(s), tag selection, attachment site, and spacer requirements (project-dependent).

2) Conjugate

Perform controlled affinity tag conjugation using site-defined chemistry to minimize heterogeneity.

3) Purify & confirm

Purification and fit-for-purpose analytical confirmation aligned to research needs.

Fastest quoting tip: Share peptide sequence(s), preferred tag (biotin/desthiobiotin/DIG/DNP), attachment site preference (or “recommend best site”), spacer preference (if any), quantity/purity targets, and intended assay format.

QC & deliverables

Standard analytical confirmation

  • Analytical HPLC/UPLC purity profile
  • LC–MS identity confirmation (when feasible)
  • COA + method summary

Fit-for-purpose purification

  • Preparative purification when required
  • Desalting / buffer exchange (project-dependent)
  • Handling aligned to assay needs

Documentation

  • Sequence and modification summary
  • Analytical traces (as applicable)
  • Notes aligned to intended research use

Our Quality Commitment

Bio-Synthesis follows controlled workflows and quality practices aligned with Total Quality Management (TQM). For affinity-tagged peptides, emphasis is placed on attachment-site control, spacer selection, purification strategy, and fit-for-purpose analytical confirmation to support research-stage reproducibility.

  • Purity profiling: analytical HPLC/UPLC
  • Identity confirmation: LC–MS when feasible
  • Reproducibility: site-defined attachment to reduce heterogeneity
  • Documentation: COA and method summary aligned to intended use

FAQ

Do you provide biotinylated peptides?

Yes. We support biotinylated peptides using site-defined attachment (N-/C-terminus or single-Cys; project-dependent) and spacer options (e.g., PEG) when needed for accessibility.

When should I use desthiobiotin instead of biotin?

Desthiobiotin is often considered when reversible capture or gentler elution is desired. Tag selection depends on your platform and assay workflow.

Can you add a spacer (PEG) between peptide and tag?

Yes. Spacers (including PEG) can improve tag accessibility in bead- or surface-based capture formats. Spacer length is selected based on assay geometry and peptide properties.

What do you need to start a project?

Share the peptide sequence(s), preferred tag (biotin/desthiobiotin/DIG/DNP), desired attachment site/constraints, spacer preference, quantity/purity targets, and your assay format.

Contact & quote request

For the fastest quote on peptide–affinity tag conjugation services, share your peptide sequence(s), the desired tag (biotin/desthiobiotin/DIG/DNP), preferred attachment site/constraints, spacer preference (if any), and quantity/purity targets.

Fast quote checklist

  • Peptide sequence(s) + termini state + reactive handles (Cys/Lys/azide/alkyne)
  • Requested affinity tag (biotin/desthiobiotin/DIG/DNP) + spacer preference
  • Attachment site preference (or “recommend best site”)
  • Quantity (mg), purity target, intended assay, and timeline constraints

Fastest path

Recommended Reading & Literature References

Peer-reviewed references for affinity capture systems and site-selective bioconjugation concepts (included for scientific context; not clinical claims).

  • Wilchek, M.; Bayer, E. A. The avidin–biotin complex in bioanalytical applications. Anal. Biochem. 1988. DOI
  • Green, N. M. Avidin and streptavidin. Methods Enzymol. 1990. DOI
  • Hermanson, G. T. Bioconjugate Techniques, 3rd ed.; Academic Press, 2013. (biotin/DIG/hapten labeling methods overview)
  • Hoyt, E. A.; Cal, P. M. S. D.; Oliveira, B. L.; Bernardes, G. J. L. Contemporary approaches to site-selective protein and peptide bioconjugation. Nat. Rev. Chem. 2019, 3, 147–171. DOI
E‑E‑A‑T note: References are provided for background on affinity capture and conjugation methods and do not imply clinical or therapeutic claims. Bio‑Synthesis provides custom synthesis and conjugation support; feasibility and methods are selected on a project-specific basis.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.